U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41 books (140 items)

1.
WHO Guidelines for the Treatment of Chlamydia trachomatis.

WHO Guidelines for the Treatment of Chlamydia trachomatis.

Geneva: World Health Organization; 2016.

Table of Contents

2.
WHO Guidelines for the Treatment of Neisseria gonorrhoeae.

WHO Guidelines for the Treatment of Neisseria gonorrhoeae.

Geneva: World Health Organization; 2016.

Table of Contents

3.
PDQ Cancer Information Summaries [Internet].

PDQ Cancer Information Summaries [Internet].

Bethesda (MD): National Cancer Institute (US); 2002-.

Table of Contents

4.
Food Allergy in Children and Young People: Diagnosis and Assessment of Food Allergy in Children and Young People in Primary Care and Community Settings.

Food Allergy in Children and Young People: Diagnosis and Assessment of Food Allergy in Children and Young People in Primary Care and Community Settings.

London: National Institute for Health and Clinical Excellence (NICE); 2011 Feb. (NICE Clinical Guidelines, No. 116.)

Table of Contents

5.
Antiretroviral Therapy for HIV Infection in Infants and Children: Towards Universal Access: Recommendations for a Public Health Approach: 2010 Revision.

Antiretroviral Therapy for HIV Infection in Infants and Children: Towards Universal Access: Recommendations for a Public Health Approach: 2010 Revision.

Geneva: World Health Organization; 2010.

Table of Contents

6.
Brolucizumab (Beovu): CADTH Reimbursement Review: Therapeutic area: Diabetic macular edema [Internet].

Brolucizumab (Beovu): CADTH Reimbursement Review: Therapeutic area: Diabetic macular edema [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Mar.

Table of Contents

7.
WHO guideline on school health services [Internet].

WHO guideline on school health services [Internet].

Geneva: World Health Organization; 2021.

Table of Contents

8.
Respiratory Tract Infections - Antibiotic Prescribing: Prescribing of Antibiotics for Self-Limiting Respiratory Tract Infections in Adults and Children in Primary Care.

Respiratory Tract Infections - Antibiotic Prescribing: Prescribing of Antibiotics for Self-Limiting Respiratory Tract Infections in Adults and Children in Primary Care.

London: National Institute for Health and Clinical Excellence (NICE); 2008 Jul. (NICE Clinical Guidelines, No. 69.)

Table of Contents

9.
Addendum to Jaundice in newborn babies under 28 days.

Addendum to Jaundice in newborn babies under 28 days.

London: National Institute for Health and Care Excellence (NICE); 2016 May. (Clinical Guideline, No. 98.1.)

Table of Contents

10.
Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Childhood Illnesses. 2nd edition.

Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Childhood Illnesses. 2nd edition.

Geneva: World Health Organization; 2013.

Table of Contents

11.
Surveillance Guidelines for Measles, Rubella and Congenital Rubella Syndrome in the WHO European Region.

Surveillance Guidelines for Measles, Rubella and Congenital Rubella Syndrome in the WHO European Region.

Geneva: World Health Organization; 2012 Dec.

Table of Contents

12.
Response to Measles Outbreaks in Measles Mortality Reduction Settings: Immunization, Vaccines and Biologicals.

Response to Measles Outbreaks in Measles Mortality Reduction Settings: Immunization, Vaccines and Biologicals.

Geneva: World Health Organization; 2009 Mar.

Table of Contents

13.
Manual on Paediatric HIV Care and Treatment for District Hospitals: Addendum to the Pocket Book of Hospital Care of Children.

Manual on Paediatric HIV Care and Treatment for District Hospitals: Addendum to the Pocket Book of Hospital Care of Children.

Geneva: World Health Organization; 2011.

Table of Contents

14.
Upadacitinib (Rinvoq): CADTH Reimbursement Recommendation: Indication: For the treatment of adults and adolescents 12 years of age and older with refractory moderate to severe atopic dermatitis who are not adequately controlled with a systemic treatment (e.g., steroid or biologic) or when use of those therapies is inadvisable. Upadacitinib can be used with or without topical corticosteroids [Internet].

Upadacitinib (Rinvoq): CADTH Reimbursement Recommendation: Indication: For the treatment of adults and adolescents 12 years of age and older with refractory moderate to severe atopic dermatitis who are not adequately controlled with a systemic treatment (e.g., steroid or biologic) or when use of those therapies is inadvisable. Upadacitinib can be used with or without topical corticosteroids [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Table of Contents

15.
Abrocitinib (Cibinqo): CADTH Reimbursement Recommendation: Indication: For the treatment of patients aged 12 years and older with refractory moderate to severe atopic dermatitis, including the relief of pruritus, who have had an inadequate response to other systemic drugs (e.g., steroid or biologic), or for whom these treatments are not advisable. Abrocitinib can be used with or without medicated topical therapies for atopic dermatitis [Internet].

Abrocitinib (Cibinqo): CADTH Reimbursement Recommendation: Indication: For the treatment of patients aged 12 years and older with refractory moderate to severe atopic dermatitis, including the relief of pruritus, who have had an inadequate response to other systemic drugs (e.g., steroid or biologic), or for whom these treatments are not advisable. Abrocitinib can be used with or without medicated topical therapies for atopic dermatitis [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Sep.

Table of Contents

16.
Otitis media with effusion in under 12s.

Otitis media with effusion in under 12s.

London: National Institute for Health and Care Excellence (NICE); 2023 Aug 30. (NICE Guideline, No. 233.)

Table of Contents

17.
Prevention and Treatment of Mpox [Internet].

Prevention and Treatment of Mpox [Internet].

McLean JR, Zucker JE, Vail RM, et al.

Baltimore (MD): Johns Hopkins University; 2024 May.

Table of Contents

18.
CADTH Canadian Drug Expert Committee Recommendation: Cysteamine Ophthalmic Solution (Cystadrops — Recordati Rare Diseases Canada Inc.): Indication: Treatment of corneal cystine crystal deposits (CCCDs) in adults and children from 2 years of age with cystinosis [Internet].

CADTH Canadian Drug Expert Committee Recommendation: Cysteamine Ophthalmic Solution (Cystadrops — Recordati Rare Diseases Canada Inc.): Indication: Treatment of corneal cystine crystal deposits (CCCDs) in adults and children from 2 years of age with cystinosis [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jun.

Table of Contents

19.
CADTH Canadian Drug Expert Committee Recommendation: Dupilumab (Dupixent — Sanofi-Aventis Canada Inc.): Indication: Atopic dermatitis [Internet].

CADTH Canadian Drug Expert Committee Recommendation: Dupilumab (Dupixent — Sanofi-Aventis Canada Inc.): Indication: Atopic dermatitis [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Jul.

Table of Contents

20.
Faricimab (Vabysmo): CADTH Reimbursement Recommendation: Indication: For the treatment of diabetic macular edema [Internet].

Faricimab (Vabysmo): CADTH Reimbursement Recommendation: Indication: For the treatment of diabetic macular edema [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Oct.

Table of Contents

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Search details

See more...

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...